Jump to content
Paul Edwards

9 in 10 men with advanced prostate cancer had gene mutations that could be targeted with drugs.

Recommended Posts

Paul Edwards

Thanks to  Chuck Maack for alerting us to this.

 

 

A collaboration between leading US and British Cancer Centres has been described as a landmark study.  Click on this link to read a report of the study.

 

 

Chuck's comment

This appears to be terrific news.  The problem now is whether or not the researchers get fast-track funding to continue their research to determine which medications currently are correct for which genomic defects, and what medications are available and might be used singularly or in combination with other medications to go after the other genomic defects.

 

Then…and we don’t know when…we are going to need government approval for coverage for the gene testing that will permit Medicare to cover that expense.....

 

And (another) then, we will need FDA approval (in Australia, TGA approval) for those medications not yet developed/determined or approved for prostate cancer, but now necessary, as well as may need combining with other medications. 

 

So, it looks like now it will be a matter of time and how fast-track they continue this research.

 

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


×
×
  • Create New...